Ironwood Pharmaceuticals | IRWD - Ordinary Share Capital


Ironwood Pharmaceuticals reported $160K in Ordinary Share Capital for its fiscal quarter ending in December of 2024.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 169.18M 470K Dec/2025
Agios Pharmaceuticals USD 58.45M 169K Dec/2025
Akebia Therapeutics USD 2K 0 Mar/2025
Almirall EUR 214.79M 0 Dec/2025
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
Amarin USD 20.8M 28K Sep/2025
Ardelyx USD 238.02M 1.13M Dec/2024
Astellas Pharma JPY 1.79B 195K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
Charles River Laboratories USD 49.22M 2K Dec/2025
Coherus Biosciences USD 12K 0 Mar/2025
Emergent BioSolutions USD 100K 0 Jun/2023
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Exact Sciences USD 189.45M 232K Sep/2025
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
Karyopharm Therapeutics USD 13K 0 Sep/2024
Lexicon Pharmaceuticals USD 363.47M 67K Dec/2025
MacroGenics USD 63.26M 62.63M Sep/2025
Moderna USD 391M 2M Sep/2025
Myriad Genetics USD 93.1M 0 Sep/2025
Pacira USD 41.12M 1.85M Dec/2025
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Puma Biotechnology USD 5K 0 Jun/2024
Sarepta Therapeutics USD 104.96M 196K Dec/2025
Takeda JPY 1.58B 2K Dec/2025
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
Vanda Pharmaceuticals USD 58K 0 Dec/2024